Abstract:Background: The financial relationship between physicians and industries has become a hotly debated issue globally. The Physician Payments Sunshine Act of the US Affordable Care Act (2010) promoted transparency of the transactions between industries and physicians by making remuneration data publicly accessible in the Open Payments Program database. Meanwhile, according to the World Health Organization, the majority of all noncommunicable disease deaths were caused by cardiovascular disease. Objective: This study aimed to investigate the distribution of non-research and non-ownership payments made to thoracic surgeons, to explore the regularity of financial relationships between industries and thoracic surgeons. Methods: Annual statistical data were obtained from the Open Payments Program general payment dataset from 2014-2016. We characterized the distribution of annual payments with single payment transactions greater than US $10,000, quantified the major expense categories (eg, Compensation, Consulting Fees, Travel and Lodging), and identified the 30 highest-paying industries. Moreover, we drew out the financial relations between industries to thoracic surgeons using chord diagram visualization. Results: The three highest categories with single payments greater than US $10,000 were Royalty or License, Compensation, and Consulting Fees. Payments related to Royalty or License transferred from only 5.38% of industries to 0.75% of surgeons with the highest median (US $13,753, $11,992, and $10,614 respectively) in 3-year period. In contrast, payments related to Food and Beverage transferred from 93.50% of industries to 98.48% of surgeons with the lowest median (US $28, $27, and $27). The top 30 highest-paying industries made up approximately 90% of the total payments (US $21,036,972, $23,304,996, and $28,116,336). Furthermore, just under 9% of surgeons received approximately 80% of the total payments in each of the 3 years. Specifically, the 100 highest cumulative payments, accounting for 52.69% of the total, transferred from 27 (6.05%) pharmaceutical industries to 86 (1.89%) thoracic surgeons from 2014-2016; 7 surgeons received payments greater than US $1,000,000; 12 surgeons received payments greater than US $400,000. The majority (90%) of these surgeons received tremendous value from only one industry. Conclusions: There exists a great discrepancy in the distribution of payments by categories. Royalty or License Fees, Compensation, and Consulting Fees are the primary transferring channels of single large payments. The massive transfer from industries to surgeons has a strong "apical dominance" and excludability. Further research should focus on discovering the fundamental driving factors for the strong concentration of certain medical devices and how these payments will affect the industry itself.

Robotics, money and research: is data or physician payments driving robotic bariatric surgery literature?

Mandate to evaluate robotic surgery implementation: a 12-year retrospective analysis of impact and future implications

Costs of Robotic and Laparoscopic Bariatric Surgery: A Retrospective Propensity Score-matched Analysis

Industry Payments and Academic Influence in Reconstructive Microsurgery

Conflicts of Interest in Bronchoscopy Research: Is Self-Reporting Sufficient?

[Radiochemical methods in clinical chemistry].

Medical malpractice in robotic surgery: a Westlaw database analysis

An MBSAQIP Analysis of 318,151 Patients

Industry Payments to Adult Reconstruction-Trained Orthopedic Surgeons: An Analysis of the Open Payments Database From 2014 to 2019

[Alveolar socket repair in rats treated with sugar cane brandy. Histological study].

Mining Open Payments Data: Analysis of Industry Payments to Thoracic Surgeons From 2014-2016

The ethical landscape of robot-assisted surgery. A systematic review

The cost of robotics: an analysis of the added costs of robotic-assisted versus laparoscopic surgery using the National Inpatient Sample

Association of Compensation From the Surgical and Medical Device Industry to Physicians and Self-declared Conflict of Interest

Retrospective cost analysis of robotic and laparoscopic anti-reflux surgery and paraesophageal hernia repair

Is robotic right colectomy economically sustainable? a multicentre retrospective comparative study and cost analysis

Cost Analysis of Robotic versus Standard Laparoscopic Hysterectomies: A Preliminary Analysis

Why healthcare executives should support a national cost containment plan.

Growth Retardation of Lymphosarcoma Implants in Pyridoxine-Deficient Rats by Testosterone and Cortisone

An Analysis of Clinical and Financial Outcomes from a Tertiary Referral Center

Cost analysis of robotic versus laparoscopic general surgery procedures